[1. Solovic I, Lassan S, Smolkova K. SEVERCA- nové vyhodnotenie závažnosti CHOCHP. In: Respiro. 2014, roč. 12, č. 2, s. 70 - 79. ISSN 1335-3985.]Search in Google Scholar
[2. Rozborilova E.Manažment chronickej obštrukčnej choroby pľúc z ekonomickej stránky. In: Respiro. 2014, roč. 12, č. 2, s. 60 - 69. ISSN 1335-3985.]Search in Google Scholar
[3. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: http://www.goldcopd.org/.]Search in Google Scholar
[4. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. Available from: http://www.goldcopd.org/.]Search in Google Scholar
[5. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015. Available from: http://www.goldcopd.org/.]Search in Google Scholar
[6. Kasak V. Chronická bostrukční plicní nemoc z pohledu farmakoekonomiky. In: Studia pneumologica et phthiseologica. 2012, roč. 72, č. 2, s. 54 - 62. ISSN 1213-810X.]Search in Google Scholar
[7. Salinas, Gregory D. et al. Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians. In: International Journal of Chronic Obstructive Pulmonary Disease. 2011, roč. 6, s. 171 - 179.]Search in Google Scholar
[8. Rea H, Kenealy T, Adair J. Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD. In: International Journal of Chronic Obstructive Pulmonary Disease. 2011; č.6, s. 527-532.]Search in Google Scholar
[9. Bencova A. et al. Komorbidity a chronická obštrukčná choroba pľúc. In: Studia pneumologica et phthiseologica. 2014, roč. 74, č. 2/2014, s. 65 - 73.]Search in Google Scholar
[10. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015. Available from: http://www.goldcopd.org/]Search in Google Scholar
[11. https://www.portaludzs.sk/web/eportal/]Search in Google Scholar
[12. Kos, S, Weber M. Národní klinický registr CERTIMA segment CHOPN- výsledky 2. roku sledování nemocných. Studia pneumologica et phthiseologica. 2014, roč. 74, č. 2, s. 62 - 64.]Search in Google Scholar
[13. De Coster, Daan A., Jones M. Tailoring of corticosteroids in COPD management. Current Respiratory Care Reports [online]. 2014, 3 (3): 121 - 132.10.1007/s13665-014-0084-2411368525089228]Search in Google Scholar
[14. Fexer J, et al. The Effects of Theophylline on Hospital Admissions and Exacerbations in COPD Patients. Deutsches Ärzteblatt International 2014, 111 (17): 293 - 300.10.3238/arztebl.2014.0293409804524828099]Search in Google Scholar
[15. Soriano JB. et al. Distribution and prognostic validity of the new global initiative for chronic obstructive lung disease grading classification. Chest 2013, 143 (3): 694 - 702.10.1378/chest.12-105323187891]Search in Google Scholar
[16. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. The Lancet 374, č. 9691. [cit. 13.10.2013], s. 721 - 732. ISSN 0140-6736.]Search in Google Scholar